Published in Proc Natl Acad Sci U S A on September 23, 2008
Seroepidemiology of human polyomaviruses. PLoS Pathog (2009) 4.62
Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host Microbe (2010) 3.78
Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens. J Virol (2010) 2.88
Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int J Cancer (2009) 2.77
Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer (2010) 2.68
Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator. J Clin Invest (2011) 2.37
Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma. J Natl Cancer Inst (2009) 2.22
Antibodies to merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in merkel cell carcinoma patients. Cancer Res (2010) 2.14
A cornucopia of human polyomaviruses. Nat Rev Microbiol (2013) 2.08
Quantitation of human seroresponsiveness to Merkel cell polyomavirus. PLoS Pathog (2009) 2.08
Taxonomical developments in the family Polyomaviridae. Arch Virol (2011) 2.03
Clusters of nucleotide substitutions and insertion/deletion mutations are associated with repeat sequences. PLoS Biol (2011) 1.95
Merkel cell polyomavirus expression in merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas. Am J Surg Pathol (2009) 1.79
Human skin microbiota: high diversity of DNA viruses identified on the human skin by high throughput sequencing. PLoS One (2012) 1.78
Discovery of STL polyomavirus, a polyomavirus of ancestral recombinant origin that encodes a unique T antigen by alternative splicing. Virology (2012) 1.75
Regulation of gene expression in primate polyomaviruses. J Virol (2009) 1.61
Survivin is a therapeutic target in Merkel cell carcinoma. Sci Transl Med (2012) 1.61
Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus. J Clin Invest (2012) 1.61
Quantitative detection of Merkel cell virus in human tissues and possible mode of transmission. Int J Cancer (2010) 1.53
The minimum replication origin of merkel cell polyomavirus has a unique large T-antigen loading architecture and requires small T-antigen expression for optimal replication. J Virol (2009) 1.52
Modulation of DNA damage and repair pathways by human tumour viruses. Viruses (2015) 1.49
Discovery of a novel polyomavirus in acute diarrheal samples from children. PLoS One (2012) 1.48
Merkel cell carcinoma: a virus-induced human cancer. Annu Rev Pathol (2011) 1.46
Activation of PI3K signaling in Merkel cell carcinoma. Clin Cancer Res (2012) 1.45
Merkel cell carcinoma subgroups by Merkel cell polyomavirus DNA relative abundance and oncogene expression. Int J Cancer (2010) 1.42
Detection of Merkel cell polyomavirus with a tumour-specific signature in non-small cell lung cancer. Br J Cancer (2013) 1.41
Structural Based Analyses of the JC Virus T-Antigen F258L Mutant Provides Evidence for DNA Dependent Conformational Changes in the C-Termini of Polyomavirus Origin Binding Domains. PLoS Pathog (2016) 1.40
Generation of Merkel cell polyomavirus (MCV)-like particles and their application to detection of MCV antibodies. J Clin Microbiol (2010) 1.40
Distinct merkel cell polyomavirus molecular features in tumour and non tumour specimens from patients with merkel cell carcinoma. PLoS Pathog (2010) 1.40
Merkel cell polyomavirus-specific CD8⁺ and CD4⁺ T-cell responses identified in Merkel cell carcinomas and blood. Clin Cancer Res (2011) 1.36
Merkel cell carcinoma: recent progress and current priorities on etiology, pathogenesis, and clinical management. J Clin Oncol (2009) 1.28
Merkel cell polyomavirus large T antigen disrupts host genomic integrity and inhibits cellular proliferation. J Virol (2013) 1.28
Merkel cell polyomavirus small T antigen controls viral replication and oncoprotein expression by targeting the cellular ubiquitin ligase SCFFbw7. Cell Host Microbe (2013) 1.27
Merkel cell polyomavirus: a newly discovered human virus with oncogenic potential. Virology (2013) 1.27
Hybrid capture and next-generation sequencing identify viral integration sites from formalin-fixed, paraffin-embedded tissue. J Mol Diagn (2011) 1.26
Merkel cell polyomavirus in cutaneous swabs. Emerg Infect Dis (2010) 1.25
Identification of an overprinting gene in Merkel cell polyomavirus provides evolutionary insight into the birth of viral genes. Proc Natl Acad Sci U S A (2013) 1.24
Cellular and viral factors regulating Merkel cell polyomavirus replication. PLoS One (2011) 1.21
Which are the cells of origin in merkel cell carcinoma? J Skin Cancer (2012) 1.21
Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy. Oncotarget (2016) 1.17
Distinct gene expression profiles of viral- and nonviral-associated merkel cell carcinoma revealed by transcriptome analysis. J Invest Dermatol (2012) 1.14
MCV and Merkel cell carcinoma: a molecular success story. Curr Opin Virol (2012) 1.14
Merkel cell polyomavirus large T antigen has growth-promoting and inhibitory activities. J Virol (2013) 1.14
Roles of the immune system in skin cancer. Br J Dermatol (2011) 1.12
Bromodomain protein Brd4 plays a key role in Merkel cell polyomavirus DNA replication. PLoS Pathog (2012) 1.11
The rapidly expanding family of human polyomaviruses: recent developments in understanding their life cycle and role in human pathology. PLoS Pathog (2013) 1.10
Tumor-specific T cells in human Merkel cell carcinomas: a possible role for Tregs and T-cell exhaustion in reducing T-cell responses. J Invest Dermatol (2013) 1.06
Different serologic behavior of MCPyV, TSPyV, HPyV6, HPyV7 and HPyV9 polyomaviruses found on the skin. PLoS One (2013) 1.05
Merkel cell polyomavirus strains in patients with merkel cell carcinoma. Emerg Infect Dis (2009) 1.05
Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses. Int J Biol Sci (2010) 1.05
Immunological detection of viral large T antigen identifies a subset of Merkel cell carcinoma tumors with higher viral abundance and better clinical outcome. Int J Cancer (2010) 1.03
Merkel cell polyomavirus small T antigen is oncogenic in transgenic mice. J Invest Dermatol (2014) 1.03
Immunobiology of Merkel cell carcinoma: implications for immunotherapy of a polyomavirus-associated cancer. Curr Oncol Rep (2011) 1.03
The raccoon polyomavirus genome and tumor antigen transcription are stable and abundant in neuroglial tumors. J Virol (2014) 1.03
Emerging and mechanism-based therapies for recurrent or metastatic Merkel cell carcinoma. Curr Treat Options Oncol (2013) 1.03
ATM and ATR activities maintain replication fork integrity during SV40 chromatin replication. PLoS Pathog (2013) 1.02
Activation of the PI3K/AKT pathway in Merkel cell carcinoma. PLoS One (2012) 1.02
Human polyomavirus 7-associated pruritic rash and viremia in transplant recipients. J Infect Dis (2014) 1.02
Merkel cell polyomavirus small T antigen targets the NEMO adaptor protein to disrupt inflammatory signaling. J Virol (2013) 1.01
Structures of Merkel cell polyomavirus VP1 complexes define a sialic acid binding site required for infection. PLoS Pathog (2012) 1.01
Merkel cell polyomavirus large T antigen disrupts lysosome clustering by translocating human Vam6p from the cytoplasm to the nucleus. J Biol Chem (2011) 1.01
Asymptomatic primary Merkel cell polyomavirus infection among adults. Emerg Infect Dis (2011) 0.99
Human polyomaviruses in skin diseases. Patholog Res Int (2011) 0.98
Entry tropism of BK and Merkel cell polyomaviruses in cell culture. PLoS One (2012) 0.98
Structural evaluation of new human polyomaviruses provides clues to pathobiology. Trends Microbiol (2010) 0.98
Replication, gene expression and particle production by a consensus Merkel Cell Polyomavirus (MCPyV) genome. PLoS One (2011) 0.98
Identification and validation of a novel mature microRNA encoded by the Merkel cell polyomavirus in human Merkel cell carcinomas. J Clin Virol (2011) 0.98
Characterization of an early passage Merkel cell polyomavirus-positive Merkel cell carcinoma cell line, MS-1, and its growth in NOD scid gamma mice. J Virol Methods (2012) 0.96
Whole-genome characterization and genotyping of global WU polyomavirus strains. J Virol (2010) 0.96
Host DNA damage response factors localize to merkel cell polyomavirus DNA replication sites to support efficient viral DNA replication. J Virol (2014) 0.96
Seroepidemiology of Human Polyomaviruses in a US Population. Am J Epidemiol (2015) 0.96
Development of a DNA vaccine targeting Merkel cell polyomavirus. Vaccine (2011) 0.95
Nuclear IRS-1 and cancer. J Cell Physiol (2012) 0.94
The T antigen locus of Merkel cell polyomavirus downregulates human Toll-like receptor 9 expression. J Virol (2013) 0.94
T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donors. Clin Cancer Res (2014) 0.94
Merkel cell polyomavirus small T antigen mediates microtubule destabilization to promote cell motility and migration. J Virol (2014) 0.93
Lymphotropism of Merkel cell polyomavirus infection, Nova Scotia, Canada. Emerg Infect Dis (2010) 0.93
Viruses and human cancers: a long road of discovery of molecular paradigms. Clin Microbiol Rev (2014) 0.93
Large T and small T antigens of Merkel cell polyomavirus. Curr Opin Virol (2015) 0.93
Human viruses and cancer. Viruses (2014) 0.92
MicroRNA expression patterns related to merkel cell polyomavirus infection in human merkel cell carcinoma. J Invest Dermatol (2013) 0.92
Asymmetric assembly of Merkel cell polyomavirus large T-antigen origin binding domains at the viral origin. J Mol Biol (2011) 0.92
The DNA damage response in viral-induced cellular transformation. Br J Cancer (2012) 0.92
A Comprehensive Analysis of Replicating Merkel Cell Polyomavirus Genomes Delineates the Viral Transcription Program and Suggests a Role for mcv-miR-M1 in Episomal Persistence. PLoS Pathog (2015) 0.92
Merkel cell polyomavirus in Merkel cell carcinoma of Italian patients. Virol J (2011) 0.91
Merkel cell polyomavirus and non-small cell lung cancer. Br J Cancer (2013) 0.91
Human tumour viruses and the deregulation of cell polarity in cancer. Nat Rev Cancer (2012) 0.90
From orphan virus to pathogen: the path to the clinical lab. Curr Opin Virol (2011) 0.90
High-affinity Rb binding, p53 inhibition, subcellular localization, and transformation by wild-type or tumor-derived shortened Merkel cell polyomavirus large T antigens. J Virol (2013) 0.89
Human polyomavirus reactivation: disease pathogenesis and treatment approaches. Clin Dev Immunol (2013) 0.89
Tumorigenic activity of merkel cell polyomavirus T antigens expressed in the stratified epithelium of mice. Cancer Res (2015) 0.89
The conundrum of causality in tumor virology: the cases of KSHV and MCV. Semin Cancer Biol (2013) 0.89
T-helper cell-mediated proliferation and cytokine responses against recombinant Merkel cell polyomavirus-like particles. PLoS One (2011) 0.88
Merkel cell polyomavirus: molecular insights into the most recently discovered human tumour virus. Cancers (Basel) (2014) 0.87
Replication of oral BK virus in human salivary gland cells. J Virol (2013) 0.87
A specific signature of Merkel cell polyomavirus persistence in human cancer cells. Proc Natl Acad Sci U S A (2008) 0.86
Opposing oncogenic activities of small DNA tumor virus transforming proteins. Trends Microbiol (2011) 0.86
Strategy for eliciting antigen-specific CD8+ T cell-mediated immune response against a cryptic CTL epitope of merkel cell polyomavirus large T antigen. Cell Biosci (2012) 0.86
At a crossroads: human DNA tumor viruses and the host DNA damage response. Future Virol (2011) 0.86
Merkel cell carcinoma in immunosuppressed patients. Cancers (Basel) (2014) 0.86
T antigen is bound to a host protein in SV40-transformed cells. Nature (1979) 17.78
Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science (2008) 16.60
Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell (1979) 14.05
SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell (1988) 12.69
Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A. Cell (1990) 6.12
Merkel cell carcinoma and HIV infection. Lancet (2002) 4.72
SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation. Oncogene (2005) 3.77
Frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identification of a unique deletion in the VP1 gene. Cancer Res (2008) 3.32
Common and unique features of T antigens encoded by the polyomavirus group. J Virol (1992) 3.31
Prevalence of somatic alterations in the colorectal cancer cell genome. Proc Natl Acad Sci U S A (2002) 3.25
Single-nucleotide mutation rate increases close to insertions/deletions in eukaryotes. Nature (2008) 3.13
Cyclin E-induced S phase without activation of the pRb/E2F pathway. Genes Dev (1997) 3.02
DNA tumor virus transforming proteins and the cell cycle. Curr Opin Genet Dev (1993) 2.88
Human transcriptome subtraction by using short sequence tags to search for tumor viruses in conjunctival carcinoma. J Virol (2007) 2.68
Characterization of polyoma viral DNA sequences in polyoma-induced hamster tumor cell lines. J Biol Chem (1980) 2.33
Case records of the Massachusetts General Hospital. Case 19-2008. A 63-year-old HIV-positive man with cutaneous Merkel-cell carcinoma. N Engl J Med (2008) 2.20
Polyoma virus middle T antigen and its role in identifying cancer-related molecules. Nat Rev Cancer (2002) 2.15
DnaJ/hsp40 chaperone domain of SV40 large T antigen promotes efficient viral DNA replication. Genes Dev (1997) 2.06
Enhanced transformation of human fibroblasts by origin-defective simian virus 40. Nature (1982) 1.84
DNA-binding properties of simian virus 40 T-antigen mutants defective in viral DNA replication. Mol Cell Biol (1983) 1.76
UV-B-type mutations and chromosomal imbalances indicate common pathways for the development of Merkel and skin squamous cell carcinomas. Int J Cancer (2002) 1.66
Simian virus 40 large T-antigen point mutants that are defective in viral DNA replication but competent in oncogenic transformation. Mol Cell Biol (1984) 1.51
Simian virus 40 large T antigen targets the spindle assembly checkpoint protein Bub1. Proc Natl Acad Sci U S A (2004) 1.42
Merkel-cell carcinomas in patients treated with methoxsalen and ultraviolet A radiation. N Engl J Med (1998) 1.41
Independent expression of the transforming amino-terminal domain of SV40 large I antigen from an alternatively spliced third SV40 early mRNA. EMBO J (1993) 1.39
Identification of critical elements within the JC virus DNA replication origin. J Virol (1990) 1.36
Loss of functional large T-antigen and free viral genomes from cells transformed in vitro by polyoma virus after passage in vivo as tumor cells. J Virol (1981) 1.28
Genomic instability of the host cell induced by the human papillomavirus replication machinery. EMBO J (2007) 1.27
Combined karyotyping, CGH and M-FISH analysis allows detailed characterization of unidentified chromosomal rearrangements in Merkel cell carcinoma. Int J Cancer (2002) 1.20
Mechanisms of transformation by polyoma virus middle T antigen. Biochim Biophys Acta (1989) 1.17
Merkel cell carcinoma: in vitro and in vivo characteristics of a new cell line. J Am Acad Dermatol (1993) 1.15
Characterisation of four Merkel cell carcinoma adherent cell lines. Int J Cancer (1995) 1.13
Establishment and characterization of a neuroendocrine skin carcinoma cell line. Lab Invest (1987) 1.12
Characterization of cell lines established from Merkel-cell ("small-cell") carcinoma of the skin. Int J Cancer (1993) 1.02
Simian virus 40-transformed human cells that express large T antigens defective for viral DNA replication. J Virol (1987) 0.94
Revised response criteria for malignant lymphoma. J Clin Oncol (2007) 22.19
Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science (2008) 16.60
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol (2006) 4.13
An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance. Clin Cancer Res (2012) 3.48
Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens. J Virol (2010) 2.88
Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors. Int J Cancer (2009) 2.78
Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int J Cancer (2009) 2.77
Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer (2010) 2.68
Human transcriptome subtraction by using short sequence tags to search for tumor viruses in conjunctival carcinoma. J Virol (2007) 2.68
Multiplexed detection of protein cancer markers with biobarcoded nanoparticle probes. J Am Chem Soc (2006) 2.64
Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options. Oncology (Williston Park) (2010) 2.41
Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator. J Clin Invest (2011) 2.37
Peripheral T-cell lymphoma. Blood (2011) 2.11
Peripheral T-cell lymphoma: new therapeutic strategies. Oncology (Williston Park) (2013) 2.09
Cardiovascular toxicity of biologic agents for cancer therapy. Oncology (Williston Park) (2014) 2.09
Quantitation of human seroresponsiveness to Merkel cell polyomavirus. PLoS Pathog (2009) 2.08
Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin? Annu Rev Microbiol (2003) 2.07
Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science (2002) 1.97
Association of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis. J Rheumatol (2007) 1.87
A sensitive non-radioactive northern blot method to detect small RNAs. Nucleic Acids Res (2010) 1.81
Merkel cell polyomavirus expression in merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas. Am J Surg Pathol (2009) 1.79
A phase II clinical trial of intensive chemotherapy followed by consolidative stem cell transplant: long-term follow-up in newly diagnosed mantle cell lymphoma. Br J Haematol (2007) 1.72
Extensive terminal and asymmetric processing of small RNAs from rRNAs, snoRNAs, snRNAs, and tRNAs. Nucleic Acids Res (2012) 1.66
Survivin is a therapeutic target in Merkel cell carcinoma. Sci Transl Med (2012) 1.61
Establishment of two immortalized nasopharyngeal epithelial cell lines using SV40 large T and HPV16E6/E7 viral oncogenes. Biochim Biophys Acta (2002) 1.61
Characterization of the MM.1 human multiple myeloma (MM) cell lines: a model system to elucidate the characteristics, behavior, and signaling of steroid-sensitive and -resistant MM cells. Exp Hematol (2003) 1.55
Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells. Cancer Res (2002) 1.53
T-cell non-Hodgkin lymphoma. Blood (2005) 1.53
The minimum replication origin of merkel cell polyomavirus has a unique large T-antigen loading architecture and requires small T-antigen expression for optimal replication. J Virol (2009) 1.52
Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies. Clin Cancer Res (2002) 1.48
Phase II study of alemtuzumab-rituximab therapy in previously untreated patients with chronic lymphocytic leukemia: short- and long-term outcomes. Leuk Lymphoma (2014) 1.47
Merkel cell carcinoma: a virus-induced human cancer. Annu Rev Pathol (2011) 1.46
Combination treatment of vertebral metastases using image-guided percutaneous radiofrequency ablation and vertebroplasty: a case report. Surg Neurol (2005) 1.46
Cancer metabolism as a therapeutic target. Oncology (Williston Park) (2013) 1.46
CD23+ mantle cell lymphoma: a clinical pathologic entity associated with superior outcome compared with CD23- disease. Am J Clin Pathol (2008) 1.44
Merkel cell carcinoma: incidence, mortality, and risk of other cancers. J Natl Cancer Inst (2010) 1.43
Clinical Management Updates in Mantle Cell Lymphoma. Oncology (Williston Park) (2016) 1.43
Novel biologic agents for non-Hodgkin lymphoma and chronic lymphocytic leukemia-part 2: adoptive cellular immunotherapy, small-molecule inhibitors, and immunomodulation. Oncology (Williston Park) (2015) 1.42
Update on human polyomaviruses and cancer. Adv Cancer Res (2010) 1.40
Novel biologic agents for non-Hodgkin lymphoma and chronic lymphocytic leukemia-part 1. Oncology (Williston Park) (2015) 1.40
Mechanisms of glucocorticoid-induced apoptosis in hematologic malignancies: updates. Curr Opin Oncol (2004) 1.38
Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1. Oncogene (2005) 1.34
Lipid encapsulation of arsenic trioxide attenuates cytotoxicity and allows for controlled anticancer drug release. J Am Chem Soc (2006) 1.27
Merkel cell polyomavirus small T antigen controls viral replication and oncoprotein expression by targeting the cellular ubiquitin ligase SCFFbw7. Cell Host Microbe (2013) 1.27
Glucose transporters in cancer metabolism. Curr Opin Oncol (2012) 1.25
Microsatellite instability in gastric cancer is associated with better prognosis in only stage II cancers. Surgery (2006) 1.25
Characterization of viral and human RNAs smaller than canonical MicroRNAs. J Virol (2009) 1.23
Cellular and viral factors regulating Merkel cell polyomavirus replication. PLoS One (2011) 1.21
Use of a multiantigen detection algorithm for diagnosis of Kaposi's sarcoma-associated herpesvirus infection. J Clin Microbiol (2006) 1.21
The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts preferentially with the terminal repeats of the genome in vivo and this complex is sufficient for episomal DNA replication. J Gen Virol (2003) 1.17
Multicolor microRNA FISH effectively differentiates tumor types. J Clin Invest (2013) 1.16
MCV and Merkel cell carcinoma: a molecular success story. Curr Opin Virol (2012) 1.14
Chromosomal alterations detected by comparative genomic hybridization in nonfunctioning endocrine pancreatic tumors. Cancer Genet Cytogenet (2005) 1.14
The serine/threonine kinase cyclin G-associated kinase regulates epidermal growth factor receptor signaling. Proc Natl Acad Sci U S A (2004) 1.14
Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapy. Blood (2012) 1.13
Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferation. Virchows Arch (2006) 1.09
Coupled transcriptome and proteome analysis of human lymphotropic tumor viruses: insights on the detection and discovery of viral genes. BMC Genomics (2011) 1.09
Enzastaurin (LY317615), a protein kinase Cbeta inhibitor, inhibits the AKT pathway and induces apoptosis in multiple myeloma cell lines. Mol Cancer Ther (2006) 1.09
Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells. Mol Carcinog (2003) 1.07
Merkel cell polyomavirus status is not associated with clinical course of Merkel cell carcinoma. J Invest Dermatol (2011) 1.06
The selective protein kinase C beta inhibitor enzastaurin induces apoptosis in cutaneous T-cell lymphoma cell lines through the AKT pathway. J Invest Dermatol (2006) 1.05
Coencapsulation of arsenic- and platinum-based drugs for targeted cancer treatment. Angew Chem Int Ed Engl (2009) 1.04
Steroid receptor and microRNA regulation in cancer. Curr Opin Oncol (2010) 1.04